Rostopira N, Tkáciková L, Rayevska G, Pylypenko V, Mikula I, Spivak M
Joint Stock Company DiaProph Med, Kiev, Ukraine.
Folia Microbiol (Praha). 2003;48(4):549-53. doi: 10.1007/BF02931339.
Enzyme immunoassay (EIA) using recombinant antigens for the detection of Treponema pallidum-specific antibodies in sera of syphilis patients was developed. Four low-molar-mass Treponema antigens (Tp15, Tp17, TmpA, Tp47) were investigated; 17- and 47-kDa proteins were demonstrated as immunodominant as they permitted to obtain the most sensitive EIA. Using a mixture of these proteins a 3rd-generation-EIA kit Dia-Syph was constructed, its sensitivity being 99.4% during tests of 165 sera of syphilitic patients. No false result was obtained on the commercial panel PSS01 (BBI, USA). The specificity of the elaborated test system (99.7%) was determined on 295 sera.
开发了一种使用重组抗原的酶免疫测定法(EIA),用于检测梅毒患者血清中梅毒螺旋体特异性抗体。研究了四种低分子量梅毒螺旋体抗原(Tp15、Tp17、TmpA、Tp47);17 kDa和47 kDa的蛋白质被证明是免疫显性的,因为它们能使EIA最为敏感。使用这些蛋白质的混合物构建了第三代EIA试剂盒Dia-Syph,在对165份梅毒患者血清进行检测时,其灵敏度为99.4%。在美国商业检测板PSS01(BBI)上未获得假阳性结果。在295份血清上测定了所研制检测系统的特异性(99.7%)。